Helicobacter pylori strain 22345

Helicobacter pylori strain 22345 is a Gram-negative, microaerophilic bacterium characterized by its spirilla shape and presence of flagella, allowing for a unique adaptation to its host-associated habitat. It typically exists as single cells and is classified as free-living, predominantly affecting a range of hosts, including Homo sapiens, various avian species, and other mammals such as rodents and primates. The strain thrives optimally at 37°C, fitting within the mesophilic temperature range. With a single replicon and a bilayered membrane structure, it exhibits specific biological traits that enable it to colonize and persist within the gastric environment of its hosts. Helicobacter pylori strain 22345 is notably associated with a variety of severe health conditions, including chronic gastric inflammation, peptic ulcer disease, and various forms of gastric cancer, such as gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. Additionally, it is linked to other gastrointestinal disorders like GERD and functional dyspepsia. This bacterium can provoke an asymptomatic mucosal inflammatory response, potentially leading to more severe pathologies over time, including atrophic gastritis and intestinal metaplasia. The pathogenicity of H. pylori strain 22345 in humans highlights its ecological significance within the gastric microbiome, where it can influence not only individual health outcomes but also the overall balance of gut flora, potentially impacting disease prevalence and severity in affected populations. Understanding its traits and effects is crucial for developing targeted treatments and preventive measures against the diseases it causes.